Literature DB >> 3945170

Naloxone effect on the neurological deficit induced by forebrain ischemia in rats.

C Capdeville, D Pruneau, M Allix, M Plotkine, R G Boulu.   

Abstract

The effect of naloxone upon neurologic deficit was evaluated in a model of transient forebrain ischemia in rats. Awake male Wistar rats were subjected to a 30 minute ischemia by occluding both common carotid arteries 8 days after cauterizing vertebral arteries. Administration of naloxone 1 or 5 mg/kg iv 10 minutes after carotid occlusion or 1 mg/kg iv one hour after clamp removal failed to reduce immediate and tardive neurologic postischemic deficits. On the other hand, in rats treated by a dose of 1 mg/kg naloxone 10 minutes after carotid occlusion and perfused with an additional dose of 2 mg/kg/h for 80 minutes, neurologic score was improved one hour after ischemia. However mortality was not decreased whatever was the modality of naloxone administration. This result confirms previous data showing that naloxone exerts a protective effect when given at sufficiently high dosage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945170     DOI: 10.1016/0024-3205(86)90068-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke.

Authors:  F Federico; V Lucivero; P Lamberti; A Fiore; C Conte
Journal:  Ital J Neurol Sci       Date:  1991-12

2.  Effects of delta-sleep-inducing peptide in cerebral ischemia in rats.

Authors:  A A Shandra; L S Godlevskii; A I Brusentsov; R S Vast'yanov; V A Karlyuga; A F Dzygal; B Nikel
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug

3.  PS1 FAD mutants decrease ephrinB2-regulated angiogenic functions, ischemia-induced brain neovascularization and neuronal survival.

Authors:  YoneJung Yoon; Georgios Voloudakis; Nathan Doran; Emily Zhang; Christina Dimovasili; Lei Chen; Zhiping Shao; Spyros Darmanis; Cheuk Tang; Jun Tang; Victoria X Wang; Patrick R Hof; Nikolaos K Robakis; Anastasios Georgakopoulos
Journal:  Mol Psychiatry       Date:  2020-06-15       Impact factor: 13.437

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.